1. Home
  2. TECX vs GCBC Comparison

TECX vs GCBC Comparison

Compare TECX & GCBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • GCBC
  • Stock Information
  • Founded
  • TECX 2019
  • GCBC 1889
  • Country
  • TECX United States
  • GCBC United States
  • Employees
  • TECX N/A
  • GCBC 209
  • Industry
  • TECX
  • GCBC Banks
  • Sector
  • TECX
  • GCBC Finance
  • Exchange
  • TECX Nasdaq
  • GCBC Nasdaq
  • Market Cap
  • TECX 334.4M
  • GCBC 438.4M
  • IPO Year
  • TECX 2018
  • GCBC 1998
  • Fundamental
  • Price
  • TECX $22.88
  • GCBC $25.27
  • Analyst Decision
  • TECX Strong Buy
  • GCBC
  • Analyst Count
  • TECX 5
  • GCBC 0
  • Target Price
  • TECX $79.00
  • GCBC N/A
  • AVG Volume (30 Days)
  • TECX 249.4K
  • GCBC 41.7K
  • Earning Date
  • TECX 08-13-2025
  • GCBC 07-23-2025
  • Dividend Yield
  • TECX N/A
  • GCBC 1.40%
  • EPS Growth
  • TECX N/A
  • GCBC 26.12
  • EPS
  • TECX N/A
  • GCBC 1.83
  • Revenue
  • TECX N/A
  • GCBC $74,038,000.00
  • Revenue This Year
  • TECX N/A
  • GCBC N/A
  • Revenue Next Year
  • TECX N/A
  • GCBC N/A
  • P/E Ratio
  • TECX N/A
  • GCBC $14.08
  • Revenue Growth
  • TECX N/A
  • GCBC 15.47
  • 52 Week Low
  • TECX $13.70
  • GCBC $20.00
  • 52 Week High
  • TECX $61.07
  • GCBC $37.25
  • Technical
  • Relative Strength Index (RSI)
  • TECX 53.91
  • GCBC 57.18
  • Support Level
  • TECX $21.41
  • GCBC $24.92
  • Resistance Level
  • TECX $23.87
  • GCBC $26.04
  • Average True Range (ATR)
  • TECX 1.57
  • GCBC 0.75
  • MACD
  • TECX 0.08
  • GCBC -0.03
  • Stochastic Oscillator
  • TECX 54.84
  • GCBC 68.82

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About GCBC Greene County Bancorp Inc.

Greene County Bancorp Inc is a holding firm. Its primary business involves overseeing and directing the business of The Bank of Greene County and monitoring its cash position. Through its directly and indirectly owned subsidiaries, the company engages in attracting retail deposits, along with funds generated from operations and borrowings, predominantly in one to four-family residential mortgage loans, commercial real estate mortgage loans, consumer loans, home equity loans, and commercial business loans. It also serves local municipalities' banking needs and operates a real estate investment trust.

Share on Social Networks: